Delivery Order SPE2DB24D2100-SPE2DB25FBDTD
Award Date
4/23/25
Potential Completion Date
5/14/25
Potential Value
$5.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,526.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XERMELO 250 MG TABLET 84S, a pharmaceutical product, and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of March 31, 2025 and was awarded on March 10, 2025. This contract award is associated with a larger Indefinite Delivery...
This federal contract award, valued at $5,526.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XERMELO 250 MG TABLET 84S, a prescription medication, to support federal healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
The federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order (DO) valued at $5,526.76 for the supply of XERMELO 250 MG TABLET 84S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 4, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This federal contract award, with an ID of SPE2DB22D2206|SPE2DB25FGB40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,526.76 firm fixed-price delivery order contract, which runs through April 2, 2025, is for the supply of XERMELO 250 MG TABLET 84S, a medical product. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit organization, to provide the pharmaceutical product XERMELO 250 MG TABLET 84S. The contract, valued at $19,160.74, has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this order. The contract is not associated with a larger vehicle and...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide XERMELO 250 MG TABLET 84S for a potential value of $9,232.06. The contract has a completion date of March 1, 2024 and does not include a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and serves as a key supplier of pharmaceutical products and medical supplies to the Department of Defense under...
This delivery order for $9,295.70, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, is for the purchase of 84 boxes of XERMELO 250 MG tablets with a completion date of November 6, 2023. The contract has a firm fixed price and will be performed in Conshohocken, Pennsylvania by Amerisourcebergen Drug Corporation's Corporate Office as the prime contractor. No set-aside designation was used for this procurement. The Defense Logistics Agency supports America's armed...
This federal contract award SPE2DB22D2206|SPE2DB24FHD69 was made by the Defense Logistics Agency (DLA), a defense agency, to the Corporate Office division of Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $9,232.06 firm-fixed-price delivery order is for the pharmaceutical product XERMELO 250 MG TABLET 84S. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,488.26 firm fixed-price delivery order is for the medication XELJANZ XR 11 MG TABLET, and has an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which serves...
This federal contract award, valued at $6,010.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the medication XELJANZ XR 11 MG TABLET UU 30S, and has a completion date of September 24, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...